Literature DB >> 3652525

Growth hormone treatment stimulates thymulin production in aged dogs.

B L Goff1, J A Roth, L H Arp, G S Incefy.   

Abstract

Diminished thymic morphology and function and a decreased provocative growth hormone (GH) response are characteristic of normal ageing. We have previously demonstrated that bovine growth hormone (bGH) treatment of adult dogs tends to result in a rejuvenation of thymic morphology. The purpose of this study was twofold: (1) to determine concentrations of thymulin (a thymic hormone) in plasma from dogs of various ages, and (2) to evaluate the effect of bGH administration on plasma thymulin concentration and thymus morphology in 'middle-aged' and 'old-aged' dogs. 'Young' (4 months), 'middle-aged' (33-55 months) and 'old-aged' (63-83 months) female beagles served as subjects for this study. Middle- and old-aged dogs were injected with either bGH or bovine serum albumin (control) for 1 month. Thymulin concentration in plasma was determined by the rosette-inhibition bioassay. An age-associated decline in the plasma concentration of thymulin was detected. Plasma thymulin concentration increased in every bGH-treated dog. In middle-aged but not old-aged dogs, bGH treatment resulted in rejuvenation of thymic morphological features as determined by stereological and histomorphological procedures. The results suggest that exogenous GH may be useful for restoration of some immune functions in aged individuals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652525      PMCID: PMC1542764     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Isolation, biochemical characteristics, and biological activity of a circulating thymic hormone in the mouse and in the human.

Authors:  J F Bach; M Dardenne; J M Pleau; M A Bach
Journal:  Ann N Y Acad Sci       Date:  1975-02-28       Impact factor: 5.691

2.  Regulation of growth hormone messenger RNA by thyroid and glucocorticoid hormones.

Authors:  J A Martial; J D Baxter; H M Goodman; P H Seeburg
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

Review 3.  Stereology: applications to biomedicalresearch.

Authors:  H Elias; A Hennig; D E Schwartz
Journal:  Physiol Rev       Date:  1971-01       Impact factor: 37.312

4.  Alterations of radioimmunoassayable growth hormone and prolactin during hypothroidism.

Authors:  G T Peake; C A Birge; W H Daughaday
Journal:  Endocrinology       Date:  1973-02       Impact factor: 4.736

5.  Decreased serum thymic factor activity in asthmatic children.

Authors:  E Garaci; R Ronchetti; V Del Gobbo; G Tramutoli; C Rinaldi-Garaci; C Imperato
Journal:  J Allergy Clin Immunol       Date:  1978-12       Impact factor: 10.793

6.  Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases.

Authors:  T Iwata; G S Incefy; S Cunningham-Rundles; C Cunningham-Rundles; E Smithwick; N Geller; R O'Reilly; R A Good
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

7.  Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome.

Authors:  C Franceschi; F Licastro; M Chiricolo; F Bonetti; M Zannotti; N Fabris; E Mocchegiani; M P Fantini; P Paolucci; M Masi
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

8.  Serum thymic factor activity in deficiencies of calories, zinc, vitamin A and pyridoxine.

Authors:  R K Chandra; G Heresi; B Au
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

9.  Respective influence of extrinsic and intrinsic factors on the age-related decrease of thymic secretion.

Authors:  M A Bach; G Beaurain
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

10.  Lymphocyte-mediated cytotoxicity: effects of ageing, adult thymectomy and thymic factor.

Authors:  M A Bach
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

View more
  7 in total

1.  Thymulin-based gene therapy and pituitary function in animal models of aging.

Authors:  Paula C Reggiani; Brenda Poch; Gloria M Cónsole; Omar J Rimoldi; Jose I Schwerdt; Victoria Tüngler; Margarita M Garcia-Bravo; Mireille Dardenne; Rodolfo G Goya
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

2.  Thymulin, zinc and insulin-like growth factor-I (IGF-I) activity before and during recombinant growth hormone (rec-GH) therapy in children and adults with GH deficiency.

Authors:  E Mocchegiani; A Sartorio; L Santarelli; S Ferrero; N Fabris
Journal:  J Endocrinol Invest       Date:  1996-10       Impact factor: 4.256

Review 3.  The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin.

Authors:  Paula C Reggiani; Gustavo R Morel; Gloria M Cónsole; Claudio G Barbeito; Silvia S Rodriguez; Oscar A Brown; Maria Jose Bellini; Jean-Marie Pléau; Mireille Dardenne; Rodolfo G Goya
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

4.  The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration.

Authors:  Jingling Jin; Guo-Li Wang; Xiurong Shi; Gretchen J Darlington; Nikolai A Timchenko
Journal:  Mol Cell Biol       Date:  2009-04-27       Impact factor: 4.272

5.  Identification and functional activity of prolactin receptors in thymic epithelial cells.

Authors:  M Dardenne; P A Kelly; J F Bach; W Savino
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

6.  Reversal of epigenetic aging and immunosenescent trends in humans.

Authors:  Gregory M Fahy; Robert T Brooke; James P Watson; Zinaida Good; Shreyas S Vasanawala; Holden Maecker; Michael D Leipold; David T S Lin; Michael S Kobor; Steve Horvath
Journal:  Aging Cell       Date:  2019-09-08       Impact factor: 9.304

7.  Profile of gamma-delta (γδ) T lymphocytes in the peripheral blood of crossbreed dogs during stages of life and implication in aging.

Authors:  Cristina Marchetti; Paolo Borghetti; Antonio Cacchioli; Luca Ferrari; Federico Armando; Attilio Corradi; Anna Maria Cantoni
Journal:  BMC Vet Res       Date:  2020-08-08       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.